Return to homepagePandemic Pact

StemComab Development of a HIPSCS-based cellular prototype for the study of synthetic monoclonal antibodies that neutralize the infection from SARS-COV-2 (StemComab)

  • Funded by Ministry of Education, University and Research Italy
  • Total publications:2 publications

Grant number: FISR2020IP_03161

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $61,800.58

  • Funder

    Ministry of Education, University and Research Italy

  • Principal Investigator

    N/A

  • Research Location

    Italy

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Peptide-Antibody Fusions Engineered by Phage Display Exhibit an Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants.

Peptide Platform as a Powerful Tool in the Fight against COVID-19.